Resources

Selected
  • Mpox
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

58 results found

2025 ∙ Folkhälsomyndigheten

Vaccination against mpox – a second update of vaccine recommendations due to increased spread of mpox clade 1

  • Recommendation
  • Europe
  • Sweden
  • Mpox
Download:
2024 ∙ Tanashat, M. Altobaishat, O. Sharaf, A. Hossam El Din Moawad, M. Al-Jafari, M. Nashwan, A. J.

Assessment of the knowledge, attitude, and perception of the world's population towards monkeypox and its vaccines: A systematic review and descriptive analysis of cross-sectional studies

  • All age groups
  • Healthcare workers
  • Mpox
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Taha, A. M. Mahmoud, A. M. Abouelmagd, K. Saed, S. A. A. Khalefa, B. B. Shah, S. Satapathy, P. Shamim, M. A. Sah, S. Serhan, H. A. Donovan, S. Sah, R. Barboza, J. J.

Effectiveness of a single dose of JYNNEOS vaccine in real world: A systematic review and meta-analysis

  • All age groups
  • Mpox
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2024 ∙ Liu, H. Wang, W. Zhang, Y. Wang, F. Duan, J. Huang, T. Huang, X. Zhang, T.

Global perspectives on smallpox vaccine against monkeypox: a comprehensive meta-analysis and systematic review of effectiveness, protection, safety and cross-immunogenicity

  • All age groups
  • Mpox
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Indiastari, D. Fajar, J. K. Tamara, F. Runesi, O. Hakim, L. N. Chotimah, K. Rahmani, A. Saputro, T. D. Afrilla, D. Firmansyah, E. Dau, D. Dzhyvak, V.

Global prevalence and determinants associated with the acceptance of monkeypox vaccination

  • All age groups
  • Mpox
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Leon-Figueroa, D. A. Barboza, J. J. Siddiq, A. Sah, R. Valladares-Garrido, M. J. Rodriguez-Morales, A. J.

Knowledge and attitude towards mpox: Systematic review and meta-analysis

  • All age groups
  • Mpox
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Eslami, A. Alimoghadam, S. Khoshravesh, S. Shirani, M. Alimoghadam, R. Alavi Darazam, I.

Mpox vaccination and treatment: a systematic review

  • All age groups
  • Mpox
  • Administration
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2024 ∙ Mektebi, A. Elsaid, M. Yadav, T. Abdallh, F. Assker, M. Siddiq, A. Sayad, R. Saifi, M. Farahat, R. A.

Mpox vaccine acceptance among healthcare workers: a systematic review and meta-analysis

  • Healthcare workers
  • Mpox
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Mason, L. M. K. Betancur, E. Riera-Montes, M. Lienert, F. Scheele, S.

MVA-BN vaccine effectiveness: A systematic review of real-world evidence in outbreak settings

  • All age groups
  • Mpox
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2024 ∙ Berry, M. T. Khan, S. R. Schlub, T. E. Notaras, A. Kunasekaran, M. Grulich, A. E. MacIntyre, C. R. Davenport, M. P. Khoury, D. S.

Predicting vaccine effectiveness for mpox

  • All age groups
  • Mpox
  • Modeling
Methodological quality (AMSTAR 2):
Not applicable
Loading...